Tech Company Financing Transactions
Healionics Funding Round
Keiretsu Capital and private investors participated in a $4.7 million capital raise for Healionics. The funding round was recorded on 5/14/2021.
Transaction Overview
Company Name
Announced On
5/14/2021
Transaction Type
Venture Equity
Amount
$4,700,000
Round
Undisclosed
Investors
Keiretsu Capital (Lead Investor)
Proceeds Purpose
The cash will be used to complete a second human study and obtain FDA clearance.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2121 N 35th St. 200
Seattle, WA 98103
USA
Seattle, WA 98103
USA
Phone
Website
Email Address
Overview
Healionics is a biomaterial company providing tissue regeneration and device biointegration solutions for medical device manufacturers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Connolly
Chief Operating Officer
Max Maginness
Chief Technical Officer
Andrew Marshall
Browse more venture capital transactions:
Prev: 5/14/2021: Sosivio venture capital transaction
Next: 5/14/2021: Grin Marketing venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs